Production (Stage)
VentriPoint Diagnostics Ltd.
VPTDF
$0.0919
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.44% | -6.61% | 0.29% | 11.38% | 3.70% |
| Total Depreciation and Amortization | -6.90% | -6.18% | 2.56% | 12.41% | 26.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.13% | 24.40% | -57.26% | -56.21% | -47.80% |
| Change in Net Operating Assets | 51.87% | 311.03% | 3,460.90% | 313.43% | 234.23% |
| Cash from Operations | 12.24% | 6.01% | 2.16% | 9.66% | 11.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.91% | -79.50% | -114.84% | -200.19% | -101.57% |
| Issuance of Common Stock | -- | 999.64% | -61.79% | -72.83% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,204.22% | 2,483.74% | 3,211.96% | -234.04% | -213.11% |
| Foreign Exchange rate Adjustments | -415.60% | -92.59% | 45.61% | 100.00% | 141.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.40% | 44.17% | 25.11% | 5.74% | 8.12% |